156 related articles for article (PubMed ID: 20333969)
1. [Cancer more common in diabetes. Maybe the treatment itself also plays a role].
Nilsson PM; Eliasson B
Lakartidningen; 2010 Jan 27-Feb 2; 107(4):170-1. PubMed ID: 20333969
[No Abstract] [Full Text] [Related]
2. Insulin glargine (Lantus) and cancer risk.
Med Lett Drugs Ther; 2009 Aug; 51(1319):67-8. PubMed ID: 19696708
[No Abstract] [Full Text] [Related]
3. [Insulin treatment in type 2 diabetes].
Birkeland KI
Tidsskr Nor Laegeforen; 2006 Mar; 126(7):919-20. PubMed ID: 16554885
[No Abstract] [Full Text] [Related]
4. Diabetes mellitus and the risk of cancer.
Pandey A; Forte V; Abdallah M; Alickaj A; Mahmud S; Asad S; McFarlane SI
Minerva Endocrinol; 2011 Sep; 36(3):187-209. PubMed ID: 22019750
[TBL] [Abstract][Full Text] [Related]
5. [Syndrome of chronic overdose of insulin and hypoglycemic sulfanilamide drugs].
Arzumetova DS; Saburenko MB; Shagazatova BKh; Zabikhodzhaeva GZ
Klin Med (Mosk); 1989 Apr; 67(4):99-101. PubMed ID: 2666739
[TBL] [Abstract][Full Text] [Related]
6. As the worm turns. On diabetes and obesity.
Gottlieb SH
Diabetes Forecast; 2002 Apr; 55(4):25-7. PubMed ID: 14959687
[No Abstract] [Full Text] [Related]
7. The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern.
Currie CJ; Johnson JA
Diabetes Obes Metab; 2012 Jan; 14(1):1-4. PubMed ID: 21736688
[TBL] [Abstract][Full Text] [Related]
8. Diabetes medications and cancer: a way out of uncertainty.
Gallo M; Esposito K; Giugliano D
Diabetes Res Clin Pract; 2012 Aug; 97(2):175-7. PubMed ID: 22560795
[No Abstract] [Full Text] [Related]
9. [Analog insulin requirements of the average patient. Interview by Dr. rer. nat. Anita Schweiger].
Renner MR
Fortschr Med; 1997 Apr; 115(10):8-10. PubMed ID: 9206690
[No Abstract] [Full Text] [Related]
10. Hold the insulin! Or maybe not.
Thompson R
Nursing; 2008 Dec; 38(12):28-31. PubMed ID: 19033984
[No Abstract] [Full Text] [Related]
11. Insuline glusine (Apidra): a new rapid-acting insulin.
Med Lett Drugs Ther; 2006 Apr; 48(1233):33-4. PubMed ID: 16625142
[TBL] [Abstract][Full Text] [Related]
12. Where now for insulin glargine--a time for pragmatic medicine?
Thomson GA; Craig R
Int J Clin Pract; 2009 Oct; 63(10):1413-5. PubMed ID: 19689485
[No Abstract] [Full Text] [Related]
13. [Management of diabetes in general practice--current requirements. 2: Oral antidiabetics and insulin therapy].
Mehnert H
Fortschr Med; 1994 Apr; 112(12):163-6. PubMed ID: 8200602
[TBL] [Abstract][Full Text] [Related]
14. [Diabetes mellitus type II: when convert to insulin?].
Bianda TL; Spinas GA
Praxis (Bern 1994); 1997 Sep; 86(38):1453-7. PubMed ID: 9381045
[TBL] [Abstract][Full Text] [Related]
15. The economic effect of hypoglycemia in a health plan.
Heaton A; Martin S; Brelje T
Manag Care Interface; 2003 Jul; 16(7):23-7. PubMed ID: 12908214
[TBL] [Abstract][Full Text] [Related]
16. [Tactics of diabetes mellitus compensation in patients with pulmonary tuberculosis].
Karachunskiĭ MA; Fedorova VI; Beglarian NR; Iakovleva OB
Probl Tuberk; 1991; (11):55-7. PubMed ID: 1775465
[No Abstract] [Full Text] [Related]
17. [Intensive insulin therapy].
Landgraf R; Huber RM; Bachmann A; Lohr R
Dtsch Med Wochenschr; 2008 Apr; 133(17):901-12. PubMed ID: 18415916
[No Abstract] [Full Text] [Related]
18. Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus.
Crasto W; Jarvis J; Hackett E; Nayyar V; McNally PG; Davies MJ; Lawrence IG
Postgrad Med J; 2009 Apr; 85(1002):219-22. PubMed ID: 19417173
[TBL] [Abstract][Full Text] [Related]
19. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus.
Mathieu C
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394
[TBL] [Abstract][Full Text] [Related]
20. [Current insulin therapy--avoidable errors].
Mehnert H
Fortschr Med; 1998 Nov; 116(31):28-30, 32-3. PubMed ID: 9864893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
